Memorial Sloan-Kettering Cancer Center, New York, New York; Weill Cornell Medical Center, New York, New York.
Departments of Ophthalmology and Pathology, Wills Eye Hospital and Thomas Jefferson University Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
Ophthalmology. 2019 May;126(5):759-763. doi: 10.1016/j.ophtha.2018.12.011. Epub 2018 Dec 8.
GNAQ mutations have been identified in port wine stains (both syndromic and nonsyndromic) and melanocytic ocular neoplasms. This study investigates the presence of GNAQ mutations in diffuse (those associated with Sturge-Weber syndrome [SWS]) and solitary choroidal hemangiomas.
Tissue from 11 patients with the following diagnoses: port wine stain (n = 3), diffuse choroidal hemangioma (n = 1), solitary choroidal hemangioma (n = 6), and choroidal nevus (n = 1).
Ten specimens were interrogated with Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets, a hybridization capture-based next-generation sequencing assay for targeted deep sequencing of all exons and selected introns of 468 key cancer genes in formalin-fixed, paraffin-embedded tumors. Digital polymerase chain reaction was used to detect GNAQ Q209 mutation in 1 specimen.
Detection of GNAQ codon-specific mutation.
Activating somatic GNAQ mutations (c.547C > T; p.Arg183Cys) were found in 100% (3 of 3) of the port wine stain and in the diffuse choroidal hemangioma. Somatic GNAQ mutations (c.626A > T; p.Gln209Leu) were found in 100% (6 of 6) of the solitary choroidal hemangiomas and (c.626A > C; p.Gln209Pro) in the choroidal nevus.
GNAQ mutations occur in both diffuse and solitary hemangiomas, although at distinct codons. An R183 codon is mutant in diffuse choroidal hemangiomas, consistent with other Sturge-Weber vascular malformations. By contrast, solitary choroidal hemangiomas have mutations in the Q209 codon, similar to other intraocular melanocytic neoplasms.
GNAQ 突变已在葡萄酒色斑(包括综合征性和非综合征性)和黑色素细胞性眼部肿瘤中被发现。本研究调查弥漫性(与 Sturge-Weber 综合征[SWS]相关)和孤立性脉络膜血管瘤中 GNAQ 突变的存在。
组织来自以下诊断的 11 名患者:葡萄酒色斑(n=3),弥漫性脉络膜血管瘤(n=1),孤立性脉络膜血管瘤(n=6)和脉络膜痣(n=1)。
使用 Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets 对 10 个标本进行检测,这是一种杂交捕获基于下一代测序的检测方法,用于对福尔马林固定、石蜡包埋肿瘤中 468 个关键癌症基因的所有外显子和选定的内含子进行靶向深度测序。使用数字聚合酶链反应检测 1 个标本中的 GNAQ Q209 突变。
检测 GNAQ 密码子特异性突变。
在 100%(3/3)的葡萄酒色斑和弥漫性脉络膜血管瘤中发现了激活性体细胞 GNAQ 突变(c.547C>T;p.Arg183Cys)。在 100%(6/6)的孤立性脉络膜血管瘤中发现了体细胞 GNAQ 突变(c.626A>T;p.Gln209Leu),在脉络膜痣中发现了 c.626A>C;p.Gln209Pro)。
GNAQ 突变发生在弥漫性和孤立性血管瘤中,尽管在不同的密码子上。R183 密码子的突变在弥漫性脉络膜血管瘤中,与其他 Sturge-Weber 血管畸形一致。相比之下,孤立性脉络膜血管瘤在 Q209 密码子上发生突变,与其他眼内黑色素细胞性肿瘤相似。